ABVD is a chemotherapy regimen used as first-line treatment of Hodgkin lymphoma that is consists of concurrent treatment with the chemotherapy drugs in a 30-day cycle, Adriamycin(25 mg/m), Bleomycin(10 IU/m), Vinblastine(6 mg/m) and Dacarbazine(375 mg/m) taken from day to 15.
Typical dosages for one 28-day cycle of ABVD are as follows: 
